The results showed a significantly higher level of serum Egfl7 in these patients than healthy individuals (increased by 3.71 folds), which was consist with the elevated levels of serum Egfl7 in HCC patients [32, 49]. The gene discussed is EGFL7; the disease is hepatocellular carcinoma.